United States Pharmacopeia
The United States Pharmacopeia (USP), a prominent authority in the pharmaceutical industry, is headquartered in Rockville, Maryland, US. Founded in 1820, USP has played a pivotal role in establishing quality standards for medicines, food ingredients, and dietary supplements. With a commitment to public health, USP develops and disseminates scientifically-based standards that ensure the quality, safety, and efficacy of products. USP's core offerings include the Pharmacopeia and National Formulary, which provide comprehensive monographs and quality standards. These resources are unique in their rigorous scientific validation and global acceptance, making USP a trusted partner for manufacturers and regulators alike. Recognised for its leadership in promoting safe and effective healthcare, USP continues to influence the pharmaceutical landscape, ensuring that patients receive high-quality products worldwide.
DitchCarbon Score
How does United States Pharmacopeia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
United States Pharmacopeia's score of 18 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
United States Pharmacopeia's reported carbon emissions
The United States Pharmacopeia (USP) currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, USP is committed to addressing climate change and may be involved in broader industry initiatives aimed at sustainability and reducing environmental impact. As the organisation continues to develop its climate commitments, stakeholders can expect future updates on their emissions and reduction strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
United States Pharmacopeia is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
